Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,170 public trials 550 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test

NCT02190578

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Preventive Medicine, University of Southern California (Los Angeles) Los Angeles, California, United States
  • Therafirst Medical Center Fort Lauderdale, Florida, United States
  • New York City Department of Health and Mental Hygiene Queens, New York, United States
  • Biological Specialty Corporation Reading, Pennsylvania, United States
View Trial Details
Completed

Study of a Novel Therapeutic Vaccine for Hepatitis C Virus

NCT01094873

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +10 more
Locations
  • Wellcome Clinical Research Facility, Queen Elizabeth's Hospital, University Hospital Birmingham NHS Foundation Trust Birmingham, West Midlands, United Kingdom
  • John Radcliffe Hospital, Headley Way Headington, Oxford, United Kingdom
View Trial Details
Completed

A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV)

NCT01070407

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +10 more
Locations
  • Centre for Clinical Vaccinology and Tropical Medicine Oxford, Oxfordshire, United Kingdom
  • Wellcome Clinical Research Facility, Queen Elizabeth's Hospital, University Hospital Birmingham NHS Foundation Trust Birmingham, West Midlands, United Kingdom
View Trial Details
Completed

CSP #512 - Options in Management With Anti-Retrovirals

NCT00050089

Conditions
AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Carl T. Hayden VA Medical Center Phoenix, Arizona, United States
  • VA Medical Center, Long Beach Long Beach, California, United States
  • VA Palo Alto Health Care System Palo Alto, California, United States
  • VA San Diego Healthcare System, San Diego San Diego, California, United States
View all 30 locations
View Trial Details
Completed

ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients

NCT01464827

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations
  • Site Reference ID/Investigator# 57583 Birmingham, Alabama, United States
  • Site Reference ID/Investigator# 55530 Birmingham, Alabama, United States
  • Site Reference ID/Investigator# 55385 Dothan, Alabama, United States
  • Site Reference ID/Investigator# 55500 Phoenix, Arizona, United States
View all 97 locations
View Trial Details

Related conditions